Cargando…

Rapid and complete response to idelalisib in a case of Richter syndrome

Richter syndrome (RS) is an aggressive lymphoma arising on the back of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and is the most common B-cell malignancy in the Western world. In the majority of cases, RS presents an activated B cell (ABC) phenotype of diffuse large B-cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagacean, Cristina, Zdrenghea, Mihnea, Saad, Hussam, Berthou, Christian, Renaudineau, Yves, Tempescul, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389009/ https://www.ncbi.nlm.nih.gov/pubmed/30863085 http://dx.doi.org/10.2147/OTT.S187459

Ejemplares similares

DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag
por: Bagacean, Cristina, et al.
Publicado: (2017)

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
por: Bagacean, Cristina, et al.
Publicado: (2017)

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2019)

Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2017)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Exudative pericarditis in the evolution of a diffuse large B-cell lymphoma
por: Bagacean, Cristina, et al.
Publicado: (2015)

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
por: Bagacean, Cristina, et al.
Publicado: (2016)

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018)

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
por: Ilcus, Cristina, et al.
Publicado: (2017)

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
por: Neaga, Alexandra, et al.
Publicado: (2021)

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
por: Lamar, Zanetta, et al.
Publicado: (2015)

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
por: Debant, Marjolaine, et al.
Publicado: (2019)

Periorbital Richter Syndrome
por: Gorman, Mark, et al.
Publicado: (2015)

Richter Syndrome
por: Condoluci, Adalgisa, et al.
Publicado: (2021)

Extranodal Richter's syndrome of the urinary bladder
por: Carrión-Valencia, Almudena, et al.
Publicado: (2018)

Idelalisib: a rare cause of enterocolitis
por: Balagoni, Harika, et al.
Publicado: (2016)

The involvement of microRNA in the pathogenesis of Richter syndrome
por: Van Roosbroeck, Katrien, et al.
Publicado: (2019)

Chilaiditi's sign secondary to Richter's hernia or Chilaiditi's syndrome?
por: Shakya, Vikal Chandra
Publicado: (2015)

The Occurrence of Richter's Syndrome during Treatment with Obinutuzumab and Chlorambucil
por: Ng, Teng Fong, et al.
Publicado: (2020)

Pembrolizumab in relapsed or refractory Richter syndrome
por: Armand, Philippe, et al.
Publicado: (2020)

Rare case of Richter syndrome with testicular involvement successfully obtained good prognosis with rapid operation and immunochemotherapy
por: Kawase, Kengo, et al.
Publicado: (2019)

Durable Response to Venetoclax Monotherapy in Richter’s Syndrome: A Case Report and Review of Literature
por: Kollipara, Revathi, et al.
Publicado: (2019)

Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease
por: Le Calloch, R., et al.
Publicado: (2011)

Richter's syndrome: a novel presentation.
por: Smyth, E. F., et al.
Publicado: (2003)

Current trends in the management of Richter's syndrome
por: Allan, John N, et al.
Publicado: (2019)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Sviatoslav Richter
Publicado: (1998)

Sviatoslav Richter.
por: Beethoven, Ludwig van, 1770-1827
Publicado: (1998)

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia
por: Khan, Maliha, et al.
Publicado: (2014)

Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia
por: El-Haj, Nura, et al.
Publicado: (2014)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses
por: Alflen, Astrid, et al.
Publicado: (2018)

Infection by H1N1 flu virus revealing T-cell acute lymphoid leukaemia: about two cases
por: Lefevre, Guillaume, et al.
Publicado: (2010)

Ibrutinib has some activity in Richter's syndrome
por: Giri, S, et al.
Publicado: (2015)

Novel Approaches for the Treatment of Patients with Richter’s Syndrome
por: Iannello, Andrea, et al.
Publicado: (2022)

PB1861: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, T., et al.
Publicado: (2022)

PB1948: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, Tatyana, et al.
Publicado: (2023)

Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome
por: Ojeda-Uribe, Mario, et al.
Publicado: (2020)

The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials
por: Bagacean, Cristina, et al.
Publicado: (2022)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t53ngpms022hm21djv7o7ai910